Coloplast A/S (CLPBY)
6.10
+0.19
(+3.21%)
USD |
OTCM |
Jun 09, 16:00
Coloplast Enterprise Value : 16.22B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 16.22B |
| June 08, 2026 | 15.83B |
| June 05, 2026 | 16.01B |
| June 04, 2026 | 16.01B |
| June 03, 2026 | 15.91B |
| June 02, 2026 | 15.82B |
| June 01, 2026 | 16.03B |
| May 29, 2026 | 16.43B |
| May 28, 2026 | 16.51B |
| May 27, 2026 | 17.95B |
| May 26, 2026 | 17.77B |
| May 22, 2026 | 17.79B |
| May 21, 2026 | 18.48B |
| May 20, 2026 | 18.11B |
| May 19, 2026 | 17.75B |
| May 18, 2026 | 18.06B |
| May 15, 2026 | 17.39B |
| May 14, 2026 | 17.70B |
| May 13, 2026 | 17.75B |
| May 12, 2026 | 18.06B |
| May 11, 2026 | 17.84B |
| May 08, 2026 | 17.77B |
| May 07, 2026 | 18.04B |
| May 06, 2026 | 17.97B |
| May 05, 2026 | 17.72B |
| Date | Value |
|---|---|
| May 04, 2026 | 17.77B |
| May 01, 2026 | 17.70B |
| April 30, 2026 | 17.41B |
| April 29, 2026 | 17.43B |
| April 28, 2026 | 17.79B |
| April 27, 2026 | 17.71B |
| April 24, 2026 | 18.11B |
| April 23, 2026 | 18.13B |
| April 22, 2026 | 18.36B |
| April 21, 2026 | 18.57B |
| April 20, 2026 | 18.92B |
| April 17, 2026 | 19.35B |
| April 16, 2026 | 18.81B |
| April 15, 2026 | 18.90B |
| April 14, 2026 | 18.81B |
| April 13, 2026 | 18.67B |
| April 10, 2026 | 18.63B |
| April 09, 2026 | 18.42B |
| April 08, 2026 | 18.74B |
| April 07, 2026 | 18.29B |
| April 06, 2026 | 19.03B |
| April 02, 2026 | 19.05B |
| April 01, 2026 | 19.17B |
| March 31, 2026 | 19.05B |
| March 30, 2026 | 18.85B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ambu A/S | 2.339B |
| Abbott Laboratories | 186.33B |
| AngioDynamics, Inc. | 487.94M |
| Alphatec Holdings, Inc. | 1.742B |
| AtriCure, Inc. | 1.311B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -152.06M |
| Revenue (Quarterly) | 1.109B |
| Total Expenses (Quarterly) | 1.261B |
| EPS Diluted (Quarterly) | -0.0675 |
| Gross Profit Margin (Quarterly) | 42.95% |
| Profit Margin (Quarterly) | -13.71% |
| Earnings Yield | 2.36% |
| Operating Earnings Yield | 8.41% |
| Normalized Earnings Yield | 4.908 |